Portage Biotech (Portage Biotech) Notes Receivable : $0.00 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Portage Biotech Notes Receivable?

Portage Biotech's Notes Receivable for the quarter that ended in Dec. 2023 was $0.00 Mil.

Portage Biotech's quarterly Notes Receivable declined from Jun. 2023 ($0.44 Mil) to Sep. 2023 ($0.43 Mil) but then stayed the same from Sep. 2023 ($0.43 Mil) to Dec. 2023 ($0.00 Mil).

Portage Biotech's annual Notes Receivable stayed the same from Mar. 2021 ($0.00 Mil) to Mar. 2022 ($0.00 Mil) but then increased from Mar. 2022 ($0.00 Mil) to Mar. 2023 ($0.44 Mil).

Portage Biotech Notes Receivable Historical Data

The historical data trend for Portage Biotech's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech Notes Receivable Chart

Portage Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Notes Receivable

Get a 7-Day Free Trial

0.44

Portage Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Notes Receivable	Get a 7-Day Free Trial															0.64	0.44	0.44	0.43	-

Portage Biotech Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Portage Biotech Notes Receivable Related Terms

Thank you for viewing the detailed overview of Portage Biotech's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Portage Biotech (Portage Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110

Website

https://www.portagebiotech.com

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.